Healthy volunteers test spicy compounds to unlock nerve secrets
NCT ID NCT07237022
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at how the skin on the feet reacts to natural compounds like cinnamon, mustard, and chili. Researchers will measure blood flow and any pain in 20 healthy adults. The goal is to better understand nerve function, which may help future research on diabetic nerve damage.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
About 20 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Oct 2025
- Expected to finish
-
Aug 2026
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
Healthy male and female volunteers aged 18 to 45 years (inclusive)
- Ages
-
18 to 45 years
- Sex
-
Anyone
- Healthy volunteers
-
Accepted
You do not need to have the condition being studied to take part.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: 1. Subject is a white male or female ≥18 and ≤45 years of age 2. Subject is a non-smoker for at least 6 months prior to the start of the study 3. Subject has a body mass index (BMI) between 18-30 kg/m² 4. Subject is judged to be in good general health on the basis of medical history, physical examination and vital signs 5. Subject understands the procedures and agrees to participate in the study by giving written informed consent. Exclusion Criteria: 1. Subject has a history of any illness or disorder which, in the investigator's opinion, might confound the results of the study 2. Subject has a history of significant severe (drug) allergies 3. Subject is a female who is pregnant, breast-feeding or intends to become pregnant, or is of child-bearing potential and is not using an adequate contraceptive method 4. Subject uses any prescription or non-prescription drugs on a regular basis which, in the investigator's opinion, might confound the results of the study 5. Subject currently uses lotions, oils, depilatory preparations, makeup, or other topical treatments on the feet on a regular basis which cannot be discontinued for the duration of the study 6. Subject has eczema, scleroderma, psoriasis, dermatitis or keloids, tumors, ulcers, burns, skin flaps or grafts on the volar surface of the forearm or the dorsum of the feet, or any other skin abnormality that, in the opinion of the investigator, may interfere with the study assessments 7. Subject has excessive hair growth on the volar surface of the forearms or the dorsum of the feet 8. Subject has any of the following vital sign measurements at screening after at least 10 minutes of supine rest: Heart Rate \<40 or \>100 beats/min, Diastolic Blood Pressure \<50 or \>90 mmHg, Systolic Blood Pressure \<90 or \>140 mmHg 9. Subject is unable to refrain from drinking caffeinated beverages (e.g. coffee, tea, cola, …) 24 hours prior to each study visit. Subject is unable to limit their intake of caffeinated beverages to ≤4 cups a day throughout the study 10. Subject is unable to refrain from drinking alcohol 24 hours prior to each study visit, is currently a regular user of illegal drugs, or has a history of substance abuse (including alcohol) 11. Subject is currently participating or has been involved in testing an investigational drug in another clinical study within the last 4 weeks 12. Subject is in a situation or has a condition which, in the opinion of the investigator, may interfere with safe and optimal participation in the study
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Physiological responses are added.
Genom att skicka in godkänner du våra Användarvillkor
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
Center for Clinical Pharmacology
RECRUITINGLeuven, 3000, Belgium
More trials for these conditions
Other studies related to the condition(s) this trial covers.